HIV Cure Minisymposium
The minisymposium on state of the art HIV Cure efforts in Europe will be organized for the third time by the HIV Cure Research Center. The third edition will be organized in collaboration with the KU Leuven in the context of the Frontiers in Retrovirology conference. More information about the Frontiers in Retrovirology conference can be found here. It is possible to register for the conference, including the minisymposium, or to register only for the minisymposium.
Stably integrated HIV inside the host cell genome is considered the final hurdle to cure one of the most challenging infectious diseases humans have ever faced. Latent HIV reservoir is able to refuel infection once the treatment is stopped and therefore a better understanding of both, the composition and the size of this reservoir will be important to aid the development of cure strategies as well as to monitor the efficacy of therapeutic interventions to reduce the HIV reservoir. The HIV Cure Minisymposium will summarize the state of the art in HIV cure strategies and diagnostic tools to monitor therapeutic interventions. The Symposium will be held in the beautiful city of Leuven, Belgium and an internationally-recognized expert panel will guide you through the newest developments in the HIV cure field, focusing on reservoir characterization and novel clinical strategies to achieve HIV cure.
The Minisymposium aims to attract a broad public of basic and translational researchers with an interest in HIV research or in other persistent infectious diseases.
Program Thursday 13.09.2018
|14:00-14:30||Sarah Fidler||Imperial College London, United Kingdom||Strategies towards a cure for HIV|
|14:30-15:00||Monsef Benkirane||Institute de Génétique Humaine – Université de Montpellier,France|| 3D genome structure of primary CD4 T cell: impact on
HIV-1 integration site selection and expression
|15:00-15:30||Carine Van Lint||Université libre de Bruxelles Belgium||New factor involved in DNA methylation-mediated respression of latent HIV-1|
|16:00-16:15||Mikako Fujita||Development of a novel method for HIV eradication: “lock-in and apoptosis”|
|16:15-16:30||Anna Kula||Heterogeneous HIV reactivation patterns of DSF and combined DSF+romidepsin treatments|
|16:30-16:45||Virginie Wilhelmine Gautier||Targeting HIV latency with metabolic cue|
|16:45-17:00||Marie-Angélique De Scheerder||HCRC, UGent||The effect of Analytical Treatment Interruption on neuro inflammation, restriction factor expression and reservoir size in HIV infected individuals|
|17:00-17:15||Award Ceremony in the presence of Professor Erik De Clercq: Best Oral and Best Poster Presentation Award|
|17:15-18:00||Round Table with Alessandra Martini (European Commission), Patrick Reyntiens (Sensoa), Jean-Marc Steens (ABIVAX), and Dr. Annemarie Wensing (UMC Utrecht)|
Registration for the minisymposium is possible from 01/03/2018 until 31/08/2018 through the website of the Frontiers in Retrovirology conference 2018 in Leuven. More information can be found here.
The symposium will take place in the University Hall in Leuven. More information about the venue can be found here.
Abstract submission will open from the 1st of March until 15th of June.
Abstract content and editing are the responsibility of submitting author. Organizers will review abstracts and selections will be made based on quality of content. Dissemination of the results will be made on June 30th. 4 abstracts will be selected for a short oral presentation at the symposium and those will be awarded with complimentary registration and accommodation. All abstracts are assigned a poster number for poster presentation during a poster session during the meeting.
• 2200 characters count including spaces. Also includes title, authors and affiliations.
• No email addresses, phone numbers, hyperlinks, keyword lists, comments, text or image boxes.
• Paragraph breaks between Title, Author & Institute, and abstract body.
• Arial, 11 point, black font.
• For Greek and Scientific symbols, use the Symbol option under the Insert tab in Microsoft Word (or equivalent option in other applications).
• Single spacing, one-inch margins, left justified.
• One abstract per submitting author per meeting. Submitting author and account name must match. Submitting author must be underlined.
Submission of the abstract signifies consent to publication of the abstract in the Journal of Virus Eradication.
To submit your abstract, please send an email to email@example.com.